MOL MED 润色咨询

MOLECULAR MEDICINE

出版年份：1994 年文章数：1230 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：0.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2277091, encodeId=cf0622e709174, content=这个杂志能否两个通讯？我看投稿指南说强烈建议一个，如果写两个会被要求改成一个吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Wed Aug 13 15:29:26 CST 2025, time=2025-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2266918, encodeId=600d226691855, content=有没有最近投过这期刊的大佬，请问大约多长时间可以拒稿，我看官网上显示的是中位数3天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Tue May 27 18:47:13 CST 2025, time=2025-05-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2234267, encodeId=00e3223426ec9, content=最近发觉太慢了这个杂志，审稿专家回复意见普遍要2周左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66db9181345, createdName=ms4000001941309455, createdTime=Thu Oct 31 11:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：药理<br>经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫抑制;脓毒症<br>经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海)]
    2025-08-13 ms2000000380475116 来自北京

    这个杂志能否两个通讯？我看投稿指南说强烈建议一个，如果写两个会被要求改成一个吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2277091, encodeId=cf0622e709174, content=这个杂志能否两个通讯？我看投稿指南说强烈建议一个，如果写两个会被要求改成一个吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Wed Aug 13 15:29:26 CST 2025, time=2025-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2266918, encodeId=600d226691855, content=有没有最近投过这期刊的大佬，请问大约多长时间可以拒稿，我看官网上显示的是中位数3天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Tue May 27 18:47:13 CST 2025, time=2025-05-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2234267, encodeId=00e3223426ec9, content=最近发觉太慢了这个杂志，审稿专家回复意见普遍要2周左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66db9181345, createdName=ms4000001941309455, createdTime=Thu Oct 31 11:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：药理<br>经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫抑制;脓毒症<br>经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海)]
    2024-07-12 ms7000000563451718 来自江苏省

    巨特么慢，去年三月份投的稿现在还在外审

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2277091, encodeId=cf0622e709174, content=这个杂志能否两个通讯？我看投稿指南说强烈建议一个，如果写两个会被要求改成一个吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Wed Aug 13 15:29:26 CST 2025, time=2025-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2266918, encodeId=600d226691855, content=有没有最近投过这期刊的大佬，请问大约多长时间可以拒稿，我看官网上显示的是中位数3天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Tue May 27 18:47:13 CST 2025, time=2025-05-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2234267, encodeId=00e3223426ec9, content=最近发觉太慢了这个杂志，审稿专家回复意见普遍要2周左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66db9181345, createdName=ms4000001941309455, createdTime=Thu Oct 31 11:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：药理<br>经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫抑制;脓毒症<br>经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海)]
    2025-05-27 硅星 来自河北省

    有没有最近投过这期刊的大佬，请问大约多长时间可以拒稿，我看官网上显示的是中位数3天

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2277091, encodeId=cf0622e709174, content=这个杂志能否两个通讯？我看投稿指南说强烈建议一个，如果写两个会被要求改成一个吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Wed Aug 13 15:29:26 CST 2025, time=2025-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2266918, encodeId=600d226691855, content=有没有最近投过这期刊的大佬，请问大约多长时间可以拒稿，我看官网上显示的是中位数3天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Tue May 27 18:47:13 CST 2025, time=2025-05-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2234267, encodeId=00e3223426ec9, content=最近发觉太慢了这个杂志，审稿专家回复意见普遍要2周左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66db9181345, createdName=ms4000001941309455, createdTime=Thu Oct 31 11:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：药理<br>经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫抑制;脓毒症<br>经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海)]
    2024-10-31 ms4000001941309455

    最近发觉太慢了这个杂志，审稿专家回复意见普遍要2周左右

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2277091, encodeId=cf0622e709174, content=这个杂志能否两个通讯？我看投稿指南说强烈建议一个，如果写两个会被要求改成一个吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Wed Aug 13 15:29:26 CST 2025, time=2025-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2266918, encodeId=600d226691855, content=有没有最近投过这期刊的大佬，请问大约多长时间可以拒稿，我看官网上显示的是中位数3天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Tue May 27 18:47:13 CST 2025, time=2025-05-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2234267, encodeId=00e3223426ec9, content=最近发觉太慢了这个杂志，审稿专家回复意见普遍要2周左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66db9181345, createdName=ms4000001941309455, createdTime=Thu Oct 31 11:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：药理<br>经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫抑制;脓毒症<br>经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海)]
    2024-01-23 12唐布拉 来自浙江省

    太慢了，一个月还在找审稿人

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2277091, encodeId=cf0622e709174, content=这个杂志能否两个通讯？我看投稿指南说强烈建议一个，如果写两个会被要求改成一个吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Wed Aug 13 15:29:26 CST 2025, time=2025-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2266918, encodeId=600d226691855, content=有没有最近投过这期刊的大佬，请问大约多长时间可以拒稿，我看官网上显示的是中位数3天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Tue May 27 18:47:13 CST 2025, time=2025-05-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2234267, encodeId=00e3223426ec9, content=最近发觉太慢了这个杂志，审稿专家回复意见普遍要2周左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66db9181345, createdName=ms4000001941309455, createdTime=Thu Oct 31 11:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：药理<br>经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫抑制;脓毒症<br>经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海)]
    2022-06-08 贵中医

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：药理
    经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！

    6

    展开6条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2277091, encodeId=cf0622e709174, content=这个杂志能否两个通讯？我看投稿指南说强烈建议一个，如果写两个会被要求改成一个吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Wed Aug 13 15:29:26 CST 2025, time=2025-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2266918, encodeId=600d226691855, content=有没有最近投过这期刊的大佬，请问大约多长时间可以拒稿，我看官网上显示的是中位数3天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Tue May 27 18:47:13 CST 2025, time=2025-05-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2234267, encodeId=00e3223426ec9, content=最近发觉太慢了这个杂志，审稿专家回复意见普遍要2周左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66db9181345, createdName=ms4000001941309455, createdTime=Thu Oct 31 11:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：药理<br>经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫抑制;脓毒症<br>经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海)]
    2023-07-10 ms1000001069261709 来自湖北省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤
    经验分享：外审完了，中间没有出现under review 状态

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2277091, encodeId=cf0622e709174, content=这个杂志能否两个通讯？我看投稿指南说强烈建议一个，如果写两个会被要求改成一个吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Wed Aug 13 15:29:26 CST 2025, time=2025-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2266918, encodeId=600d226691855, content=有没有最近投过这期刊的大佬，请问大约多长时间可以拒稿，我看官网上显示的是中位数3天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Tue May 27 18:47:13 CST 2025, time=2025-05-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2234267, encodeId=00e3223426ec9, content=最近发觉太慢了这个杂志，审稿专家回复意见普遍要2周左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66db9181345, createdName=ms4000001941309455, createdTime=Thu Oct 31 11:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：药理<br>经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫抑制;脓毒症<br>经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海)]
    2023-02-12 ms7000000525998320 来自福建省

    2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2277091, encodeId=cf0622e709174, content=这个杂志能否两个通讯？我看投稿指南说强烈建议一个，如果写两个会被要求改成一个吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Wed Aug 13 15:29:26 CST 2025, time=2025-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2266918, encodeId=600d226691855, content=有没有最近投过这期刊的大佬，请问大约多长时间可以拒稿，我看官网上显示的是中位数3天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Tue May 27 18:47:13 CST 2025, time=2025-05-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2234267, encodeId=00e3223426ec9, content=最近发觉太慢了这个杂志，审稿专家回复意见普遍要2周左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66db9181345, createdName=ms4000001941309455, createdTime=Thu Oct 31 11:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：药理<br>经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫抑制;脓毒症<br>经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海)]
    2023-06-21 ms3000000528495608 来自辽宁省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：免疫抑制;脓毒症
    经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2277091, encodeId=cf0622e709174, content=这个杂志能否两个通讯？我看投稿指南说强烈建议一个，如果写两个会被要求改成一个吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Wed Aug 13 15:29:26 CST 2025, time=2025-08-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2266918, encodeId=600d226691855, content=有没有最近投过这期刊的大佬，请问大约多长时间可以拒稿，我看官网上显示的是中位数3天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Tue May 27 18:47:13 CST 2025, time=2025-05-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2234267, encodeId=00e3223426ec9, content=最近发觉太慢了这个杂志，审稿专家回复意见普遍要2周左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66db9181345, createdName=ms4000001941309455, createdTime=Thu Oct 31 11:37:30 CST 2024, time=2024-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：药理<br>经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：免疫抑制;脓毒症<br>经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海)]
    2022-12-11 jiafeimao123 来自上海

    审稿速度:24.0 | 投稿命中率:5.0
    经验分享：一切都太慢了，没有之一

    0

共77条页码: 1/8页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分